V
主页
Removing analytical bottlenecks in cell therapy
发布人
打开封面
下载高清视频
观看高清视频
视频下载器
All you need for T cell research
Industrialization of Cell Therapy Manufacturing
Cell therapy logistics_ Exploring the last 100m
Understanding & predicting outcomes in CAR T-cell therapy
Utilizing the Gibco CTS Rotea System for cell and gene therapy development
Meeting Regulatory Requirements for Cell and Gene Therapy Manufacturing
Off-the-shelf NK cell therapy [WEBINAR]
Stem Cell Therapie's Potential in the Pandemic Era
Simplifying GMP CAR T and CAR NK cell therapy manufacturing processes
2022 WMIF,The Cell Therapy Landscape,CAR-T to Stem Cells
GMP requirements for cell and gene therapy institutions
2022 WMIF,Cell Therapy and Transplantation for Parkinson'sease
CAR-T Cell Therapy_ Now and in 2030
GMP Raw Materials for Cell Therapy - What, When, How?
A cGMP Compatible, Non-Viral CAR T Cell Manufacturing Process
High-Quality Plasmid DNA Manufacturing Strategies for Gene and Cell Therapeutics
CAR-T Generation for Identity, Purity and Potency Assay Testing
Addressing the challenges of cell and gene therapy manufacturing
Keynote_ Carl June | Therapy Gladstone-UCSF
How cell and gene therapies can transform the treatment of solid tumours
A CRISPR Vision for the Future of Cell Therapy
High Cell Density and Perfusion Process Solutions
Lentivirus vector manufacturing using suspension cell line
Blocking ADAM17 as a therapeutic approach to increase human NK cell proliferatio
实验室记录与数据管理
Dr. Carl June Presenting at Nobel Conference
计算机化系统GMP要求
温度分布验证相关考虑
生物制药质量管理
VHP气相灭菌技术
FT596_ iPSC-derived CAR-NK cells with engineered persistence for B-cell malignan
Fate Therapeutics Introduction
Bioreactor discussion
包材相容性密封性
CAR-T细胞治疗优劣及发展方向
Megakaryopoiesis
生物大分子与细胞冻融工艺应用
湿热灭菌的科学原理
生物制药的GMP检查要求
CFDI《细胞质量产品GMP指南》解读